These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 32311107)
1. Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients. Finsterer J; Stollberger C J Med Virol; 2020 Oct; 92(10):1793-1794. PubMed ID: 32311107 [No Abstract] [Full Text] [Related]
2. Prospective Study in 355 Patients With Suspected COVID-19 Infection: Value of Cough, Subjective Hyposmia, and Hypogeusia. Martin-Sanz E; Riestra J; Yebra L; Larran A; Mancino F; Yanes-Diaz J; Garrote M; Colmenero M; Montiel E; Molina C; Moreno D; Rodriguez A; Monedero G; Sanz-Fernández R; Gonzalez R; Esteban-Sanchez J Laryngoscope; 2020 Nov; 130(11):2674-2679. PubMed ID: 32686164 [TBL] [Abstract][Full Text] [Related]
3. Association of COVID-19 with Anosmia and Hypogeusia. Nasir S; Iftikhar PM Am J Med Sci; 2020 Oct; 360(4):414. PubMed ID: 32703532 [No Abstract] [Full Text] [Related]
4. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection. Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645 [TBL] [Abstract][Full Text] [Related]
5. [Anosmia and ageusia as primary symptoms of COVID-19]. Haldrup M; Johansen MI; Fjaeldstad AW Ugeskr Laeger; 2020 Apr; 182(18):. PubMed ID: 32400371 [TBL] [Abstract][Full Text] [Related]
6. Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? Bozzetti S; Ferrari S; Zanzoni S; Alberti D; Braggio M; Carta S; Piraino F; Gabbiani D; Girelli D; Nocini R; Monaco S; Crisafulli E; Mariotto S Immunol Res; 2021 Dec; 69(6):553-557. PubMed ID: 34363587 [TBL] [Abstract][Full Text] [Related]
7. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Vaira LA; Salzano G; Fois AG; Piombino P; De Riu G Int Forum Allergy Rhinol; 2020 Sep; 10(9):1103-1104. PubMed ID: 32342636 [No Abstract] [Full Text] [Related]
8. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia. Mubaraki AA; Alrbaiai GT; Sibyani AK; Alhulayfi RM; Alzaidi RS; Almalki HS Saudi Med J; 2021 Jan; 42(1):38-43. PubMed ID: 33399169 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature. Birlutiu V; Feiereisz AI; Oprinca G; Dobritoiu S; Rotaru M; Birlutiu RM; Iancu GM Int J Infect Dis; 2021 Jun; 107():72-77. PubMed ID: 33887455 [TBL] [Abstract][Full Text] [Related]
10. Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology. Pallanti S Compr Psychiatry; 2020 Jul; 100():152184. PubMed ID: 32422426 [TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy. Berte' R; Mazza S; Stefanucci MR; Noviello D; Costa S; Ciafardini C; Mileti E; Mapelli M; Pasqualato S; Pinto S; Favale A; Vecchi M; Neurath MF; Atreya R; Fantini MC; Facciotti F; Caprioli F J Crohns Colitis; 2021 May; 15(5):864-868. PubMed ID: 33211810 [TBL] [Abstract][Full Text] [Related]
12. Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients. Algahtani SN; Alzarroug AF; Alghamdi HK; Algahtani HK; Alsywina NB; Bin Abdulrahman KA Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162068 [TBL] [Abstract][Full Text] [Related]
13. The aftermath of COVID-19: between anosmia and ageusia. Medina Gamero A; Regalado Chamorro M; Guillen Rojas N Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(3):200. PubMed ID: 35577438 [No Abstract] [Full Text] [Related]
15. Scientists deliberately gave people COVID - here's what they learnt. Callaway E Nature; 2022 Feb; 602(7896):191-192. PubMed ID: 35110709 [No Abstract] [Full Text] [Related]
16. Neurological features and outcome in COVID-19: dementia can predict severe disease. Ghaffari M; Ansari H; Beladimoghadam N; Aghamiri SH; Haghighi M; Nabavi M; Mansouri B; Mehrpour M; Assarzadegan F; Hesami O; Sedaghat M; Farahbakhsh M; Lima BS J Neurovirol; 2021 Feb; 27(1):86-93. PubMed ID: 33417193 [TBL] [Abstract][Full Text] [Related]
17. Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms. Brechbühl J; Lopes AC; Wood D; Bouteiller S; de Vallière A; Verdumo C; Broillet MC Commun Biol; 2021 Jul; 4(1):880. PubMed ID: 34267318 [TBL] [Abstract][Full Text] [Related]
18. In Response to Anosmia and Ageusia: Common Findings in COVID-19 Patients. Vaira LA; Salzano G; Deiana G; De Riu G Laryngoscope; 2020 Nov; 130(11):E695. PubMed ID: 32673407 [No Abstract] [Full Text] [Related]
19. Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study. Nouchi A; Chastang J; Miyara M; Lejeune J; Soares A; Ibanez G; Saadoun D; Morélot-Panzini C; Similowski T; Amoura Z; Boddaert J; Caumes E; Bleibtreu A; Lorenzo A; Tubach F; Pourcher V Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):691-697. PubMed ID: 33033955 [TBL] [Abstract][Full Text] [Related]
20. Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia. Koyama S; Kondo K; Ueha R; Kashiwadani H; Heinbockel T Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]